FWP 23.26 Forward Pharma A/S $FWP Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
FWP 23.26 Forward Pharma A/S $FWP Hit a 52 week high of 25.08 Currently at 23.26 +0.05 +0.22% With a day low of 23.04 and a total volume of 9,906.

FWP Forward Pharma A/S Recent Headline News

U.S. IPO Weekly Recap: 5 IPOs Achieve Moderate Gains During The Market Slide And A Biotech Rejection
Renaissance Capital IPO Research - at Seeking Alpha - Sun Oct 19, 12:54PM CDT
Five initial public offerings collectively raised $1.3 billion during the past week, bringing the year's total to 228 IPOs and $73.5 billion raised, a 35% increase over this time last year by deal count and an 84% increase by proceeds. The S&P...
DM: 34.29 (+0.67), FWP: 23.09 (-0.12), ATRA: 27.97 (+1.55), ZAYO: 23.11 (-0.41), GWB: 20.21 (-0.14)

IPO Stock Watch: Biotech Forward Pharma Falls On IPO
at Investor's Business Daily - Wed Oct 15, 3:06PM CDT
Forward Pharma, the largest biotech IPO this year, tanked on its first day of trading. Denmark-based Forward Pharma (FWP) raised $221 million by pricing 10.5 million shares at 21, the midpoint of its 20-22 range. The stock was trading near 17.50,...
DM: 34.29 (+0.67), BIIB: 327.05 (-0.82), KITE: 42.00 (-0.86), FWP: 23.09 (-0.12), XENE: 17.75 (+1.75), ATRA: 27.97 (+1.55), VBAY: (), GWB: 20.21 (-0.14)

Nasdaq Welcomes Forward Pharma A/S (Nasdaq: FWP) to The Nasdaq Stock Market
GlobeNewswire - Wed Oct 15, 10:42AM CDT
Nasdaq (Nasdaq:NDAQ) announced that trading of Forward Pharma A/S (Nasdaq:FWP) commenced on The Nasdaq Stock Market on October 15, 2014.
FWP: 23.09 (-0.12), NDAQ: 44.28 (+0.25)

Forward Pharma A/S Prices Initial Public Offering of ADSs
PR Newswire - Wed Oct 15, 7:00AM CDT
Forward Pharma A/S, a biopharmaceutical company working to advance a proprietary formulation of dimethyl fumarate for the treatment of multiple sclerosis and other immune disorders such as psoriasis, today announced the pricing of its initial public offering of 10,500,000 American Depositary Shares ("ADSs", representing the Company's ordinary shares, at a price to the public of $21.00 per ADS. The ADSs are expected to begin trading today on the NASDAQ Global Select Market under the ticker symbol "FWP". The Company has granted the underwriters a 30-day option to purchase up to an additional 1,575,000 ADSs to cover over-allotments, if any.
FWP: 23.09 (-0.12)

Forward Strides For Forward Pharma At Its IPO
Don Dion - at Seeking Alpha - Wed Oct 15, 3:05AM CDT

FWP: 23.09 (-0.12)

IPO Preview: Forward Pharma A/S
IPOdesktop - at Seeking Alpha - Wed Oct 15, 1:55AM CDT
Based in Copenhagen, Denmark, Forward Pharma A/S (Pending: FWP ) scheduled a $200 million IPO on the Nasdaq with a market capitalization of $941 million at a price range midpoint of $21 for Wednesday, October 15, 2014. The full IPO calendar is...
FWP: 23.09 (-0.12)

Biotechs lead list of 7 IPOs
at Investor's Business Daily - Mon Oct 13, 5:46PM CDT
Four more biotech IPOs are scheduled to debut this week. Forward Pharma (FWP) looks to raise $200 mil by offering 9.5 mil shares at a price range of 20-22. Atara Biotherapeutics (ATRA) plans to raise $75 mil by selling 5 mil shares at 14-16. Xenon...
FWP: 23.09 (-0.12), XENE: 17.75 (+1.75), ATRA: 27.97 (+1.55), VBAY: ()

IPO Calendar: Biotech Companies Lead List Of 7 IPOs
at Investor's Business Daily - Mon Oct 13, 3:33PM CDT
In a big year for biotech IPOs, four more are scheduled to debut this week, including the year's largest -- Forward Pharma. Seven initial public offerings in total are expected this week, looking to raise a combined $1.7 billion. Forward Pharma (FWP)...
DM: 34.29 (+0.67), BIIB: 327.05 (-0.82), FWP: 23.09 (-0.12), KITE: 42.00 (-0.86), XENE: 17.75 (+1.75), MRK: 59.63 (+0.82), CFG: 23.96 (+0.01), ZAYO: 23.11 (-0.41), ATRA: 27.97 (+1.55), TEVA: 58.51 (+0.47), VBAY: (), GWB: 20.21 (-0.14)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces Lawsuit as FTC Alleges Privacy Breach

Updated Category News Views 4

FTC Cracks Down on Hims & Hers Privacy Practices Most folks don't wake up wanting to find their investments tangled in legal drama. But here we are with Hims & Hers Health (NYSE: HIMS), facing fire from the Federal Trade Commission (FTC). They’re being called out for allegedly spilling the beans on users' sensitive health data—something they claimed to keep under...

Continue Reading
Sarepta Under Scrutiny: KSF's Investigation Deepens

Updated Category News Views 5

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Continue Reading
Court Enforces Design Rights: AEKE Blocked in Germany

Updated Category News Views 10

Court's Verdict: A Lesson in Design Protection Right out the gate, the Cologne Regional Court didn't pull any punches. Speediance got their 'Gym Monster' design yanked from under AEKE over in Germany. Legal swords were drawn after Speediance spotted AEKE's fitness gear looking a bit too familiar at the FIBO trade fair. Somebody should've told AEKE that a tapped shoulder...

Continue Reading
LG's High-Purity RGB Displays Shine at IFA 2026

Updated Category News Views 2

LG's Latest Dazzler: RGB Evo Takes the Spotlight LG has never been shy about setting standards in the home entertainment sector, and they’re doing it again at IFA 2026 with their high-purity RGB displays. Make no mistake, when LG rolls out a massive LCD TV certified by TÜV Rheinland for color purity, every other home theater manufacturer is scrambling to keep up. "LG...

Continue Reading
Signant and Lothar Forge Future in Clinical Trials

Updated Category News Views 1

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Continue Reading
Carles Puyol Joins Midea at IFA 2026, Celebrating Unity

Updated Category News Views 3

Leadership, Innovation, and Soccer Collide in Berlin When you’ve got a Barcelona legend like Carles Puyol gracing an event, it's more than just fanfare. This time around, Puyol made waves at Midea's stand during IFA 2026 in Berlin, signaling a strategic power move for both Midea and FC Barcelona. We're talking about a scene where tech innovation meets world-class...

Continue Reading
Why Buyers Are Flocking to Whidbey Island Homes

Updated Category News Views 1

Something's got folks eyeing Whidbey Island like a gambler with a hot tip—and it ain't just the thrill of a vacation spot. Anyone with half a brain knows real estate moves in waves, and right now, Whidbey Island's caught some serious momentum. You can't ignore the pull of natural beauty, access to city life, and that laid-back vibe that seems to whisper "slow down and...

Continue Reading
Auto Maintenance: Key Tips for Long-Term Vehicle Health

Updated Category News Views 2

Beating Breakdown Blues: Preventative Maintenance Insights You ever look under the hood and wonder what's ticking away? Cars ain't just about turning keys and hitting gas—there's a beating heart under all that metal and rubber. That's what HelloNation's serving us here, with David Mantz and his kid, David Mantz Jr., lifting the lid on preventative maintenance. These...

Continue Reading
Midea's SpaceMaster Oven: Revolutionizing Home Pizza

Updated Category News Views 1

Oven Culture: Beyond Simple Baking When it comes to the kitchen, we're always promised more than we get. You know the spiel: the heart of the home, a place for traditions. But honestly? Most ovens are about as exciting as watching paint dry. Often too cramped, uneven, and a pain in the backside to preheat. But then, out of the burning blue, Midea comes along with their...

Continue Reading
UGREEN's AI Hub: Privacy-First Tech for Smart Homes

Updated Category News Views 1

UGREEN's Big AI Leap In the bustling scene of home tech evolution, UGREEN's throwing its hat in the ring with its latest offerings. They've just rolled out the UGREEN HomeAgent series, aiming to redefine what we think of when it comes to smart living. UGREEN, usually known for its tech gadgets, is diving headfirst into the smart home pool. These local AI hubs blend tech...

Continue Reading

Top 5 Most Recently Viewed Articles

Troilus Gold Corp. Successfully Completes Major Offering

Updated Category News Views 155

Troilus Gold Corp. Completes Significant Public Offering MONTRÉAL — Troilus Gold Corp. (“Troilus” or the “Company”, TSX: TLG, OTCQX: CHXMF; FSE: CM5R) is excited to share that it has successfully closed a major bought deal public offering, which included the full exercise of the over-allotment option. This offering has resulted in the issuance of 133,722,000...

Continue Reading
Euro Zone Households' Savings: A Path to Economic Recovery

Updated Category News Views 162

Understanding Households’ Savings Trends in the Euro Zone In recent discussions regarding economic trends, it is evident that households in the Euro zone are tightening their financial belts and focusing on saving. According to the European Central Bank (ECB), many families are prioritizing the rebuilding of their wealth that was eroded due to soaring inflation. This...

Continue Reading
Harbor Capital Enhances Industrial Reach Through Strategic Buy

Updated Category News Views 132

Harbor Capital's Expansion Strategy in Industrial Real Estate In a notable move to enhance its industrial portfolio, Harbor Capital has announced the acquisition of a significant industrial facility, located at 190 Industrial Blvd. This impressive 51,710-square-foot property is strategically positioned to support the evolving needs of logistics and manufacturing sectors....

Continue Reading
IQSTEL Reports Third Quarter Surge with $102.8 Million Revenue

Updated Category News Views 138

IQSTEL Inc. Achieves Outstanding Revenue Growth in Q3 IQSTEL Inc. (NASDAQ: IQST) has recently revealed its impressive financial performance for the third quarter, showcasing a remarkable net revenue of $102.8 million. This marks a significant 42% increase from the $72.1 million reported in the previous quarter. The latest growth figures highlight the company’s robust...

Continue Reading
Oppenheimer Affirms Support for Bicycle Therapeutics' Growth

Updated Category News Views 62

Oppenheimer's Positive Perspective on Bicycle Therapeutics Recently, Oppenheimer has underscored its supportive stance on Bicycle Therapeutics (NASDAQ: BCYC) by maintaining an Outperform rating along with a price target of $48. This affirmation is fueled by recent presentations that preview a significant radiopharmaceutical gathering and insights from the company's...

Continue Reading